Statistics for Guardant Health (id:7528 GH)

Valuation metrics

Market cap

3.58B

Enterprise value

3.91B

Trailing P/E (ttm)

-7.17

Forward P/E

-10.69

PEG ratio

-10.69

Price/Sales (ttm)

5.17

Price/Book (mrq)

-62.82

Enterprise Value/Revenue

5.64

Enterprise Value/EBITDA

-10.11

Overview

Shares outstanding

123.56M

Float

111.31M

Shares short

10.26M

% Held by insiders

0.05%

% Held by institutions

1.04%

Average volume (10 days)

2.91M

Average volume (90 days)

Price summary

52-Week low

15.81

52-Week high

37.04

52-Week change

21.15%

Beta

1.11

50-Day moving average

23.68

200-Day moving average

24.25

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-74.02%

Operating margin

-61.10%

Operational effectiveness

Return on assets

-16.08%

Return on equity

-609.28%

Income statement

Revenue (ttm)

5.70

Revenue per share (ttm)

5.70

Quarterly revenue growth (yoy)

Gross profit (ttm)

336.90M

EBITDA

-386,308,992.00

Net income to common (ttm)

-512,409,984.00

Diluted EPS (ttm)

-4.28

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.03B

Total cash per share (mrq)

8.34

Total debt (mrq)

1.34B

Total Debt/Equity (mrq)

-22.29

Current ratio (mrq)

621.60%

Book value per share (mrq)

-0.49

Cash flow

Cash flow statement

-254,072,992.00

Levered free cash flow (LFCF)

-151,071,872.00